Indian makers of Sputnik V may seek waiver for local Phase-3 trials

One of the six, Hetero Biopharma, had last fortnight obtained clearance from the subject expert committee under India’s drug controller to conduct Phase-3 trials of the Russia-developed vaccine in India. The other five may approach the Indian regulator shortly seeking the exemption.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.